“…42,44,45 Recent studies have shown that the employment of both polymeric micelles and prodrugs as a combined strategy is gaining momentum as a highly attractive and groudbreaking solution. 46,47 Prodrugs represent inactive precursors of drugs that gain activity or undergo biotransformation upon reaching the target site. 48 With significant progress in biomedical materials, a number of drug-delivering micelles have been developed, capable of specifically targeting tumor sites and delivering chemotherapy drugs.…”